ASTRAZENECA PHARMA INDIA
Back to Balance Sheet
|
ASTRAZENECA PHARMA INDIA Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹98 Cr | ₹69 Cr | ₹74 Cr | ₹45 Cr | ₹44 Cr |
What is the latest Total Non-Current Liabilities ratio of ASTRAZENECA PHARMA INDIA ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹98 Cr |
Mar2023 | ₹69 Cr |
Mar2022 | ₹74 Cr |
Mar2021 | ₹45 Cr |
Mar2020 | ₹44 Cr |
How is Total Non-Current Liabilities of ASTRAZENECA PHARMA INDIA Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹98 Cr | 41.80 | |
Mar2023 | ₹69 Cr | -6.30 | |
Mar2022 | ₹74 Cr | 65.09 | |
Mar2021 | ₹45 Cr | 1.07 | |
Mar2020 | ₹44 Cr | - |
Compare Total Non-Current Liabilities of peers of ASTRAZENECA PHARMA INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ASTRAZENECA PHARMA INDIA | ₹17,281.3 Cr | -0.5% | 6.7% | 23.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹428,533.0 Cr | -1.2% | 0.9% | 41.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,076.0 Cr | -3.7% | -1.8% | 46.1% | Stock Analytics | |
CIPLA | ₹118,723.0 Cr | -1.5% | 2.2% | 16.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,998.0 Cr | 1.4% | 10.6% | 17.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,031.0 Cr | 3.5% | 3.6% | 37.4% | Stock Analytics |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ASTRAZENECA PHARMA INDIA | -0.5% |
6.7% |
23.9% |
SENSEX | -2.3% |
-5.1% |
7.4% |
You may also like the below Video Courses